1-11 of 11
Mathias Rummel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study to Investigate the Efficacy and Safety of Eltrombopag in Combination with Dexamethasone As First-Line Treatment in Adults Patients with Newly Diagnosed Primary ITP (XPAG-ITP)

Mascha Binder, Axel Matzdorff, Falk Nimmerjahn, Mathias Rummel, Oliver Meyer, Tamara Tesanovic, Tanja Sauer
Journal: Blood
Blood (2021) 138 (Supplement 1): 3151.
https://doi.org/10.1182/blood-2021-147218
Published: 2021
Journal Articles

Outcomes for Elderly Patients (pts) with Follicular Lymphoma (FL) Using Individual Patient Data (IPD) from 5922 Pts in 18 Randomized Controlled Trials (RCTs): a Follicular Lymphoma Analysis of Surrogate Hypothesis (FLASH) Group Study

Christopher Flowers, MDMS, Fang-Shu Ou, PhD, Qian Shi, PhD, Eva Hoster, PhD, Bruce A. Peterson, MD, Howard S. Hochster, MD, Pauline Brice, MD, Marco Ladetto, MD, Wolfgang Hiddemann, MD, Robert E Marcus, Eva Kimby, MD PhD, Michael Herold, Sabine De Bedout, MD MPH, Tina Nielsen, Franck Morschhauser, Mathias Rummel, MD PhD, Anton Hagenbeek, MD PhD, Umberto Vitolo, Gilles A. Salles, Daniel Sargent, PhD
Journal: Blood
Blood (2016) 128 (22): 1102.
https://doi.org/10.1182/blood.V128.22.1102.1102
Published: 2016
Journal Articles

Effects on Survival and Neurocognitive Functions of Whole-Brain Radiotherapy (WBRT) and Autologous Stem Cell Transplantation (ASCT) as Consolidation Options after High-Dose Methotrexate-Based Chemoimmunotherapy in Patients with Newly Diagnosed Primary CNS Lymphoma (PCNSL): Results of the Second Randomization of the IELSG32 Trial

Andrés J.M. Ferreri, MD, Kate Cwynarski, MBBS, FRPATH, PhD, Elisa Jacobsen Pulczynski, MD, Christopher P. Fox, MBChB, PhD, Elisabeth Schorb, MD, Paul La Rosée, MD, Mascha Binder, MD, Alberto Fabbri, MD, Valter Torri, MD, Eleonora Minacapelli, MD, Monica Falautano, MD, Fiorella Ilariucci, MD, Achille Ambrosetti, MD, Alexander Röth, MD, Claire Jane Hemmaway, MD, Peter M Johnson, MA, MD, Kim Linton, MBChB, MRCP, PhD, Tobias Pukrop, MD, Jette Sonderskov Gorlov, MD, Monica Balzarotti, MD, Georg Hess, MD, Ulrich Keller, MD, Stephan Stilgenbauer, MD, Jens P. Panse, MD, Alessandra Tucci, MD, Lorella Orsucci, MD, Francesco Pisani, MD, Alessandro Levis, MD, Stefan W. Krause, MD, Hans-Joachim Schmoll, MD PhD, Bernd Hertenstein, MD, Mathias Rummel, MD PhD, Jeffery Smith, MD, Michael Pfreundschuh, MD, PhD, Giuseppina Cabras, MD, Francesco Angrilli, MD, Maurilio Ponzoni, MD, Martina Deckert, MD, Letterio S. Politi, MD, Jurgen Finke, MD, Michele Reni, MD, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus, MD
Journal: Blood
Blood (2016) 128 (22): 511.
https://doi.org/10.1182/blood.V128.22.511.511
Published: 2016
Journal Articles

Treatment recommendations from the Eighth International Workshop on Waldenström’s Macroglobulinemia

Véronique Leblond, Efstathios Kastritis, Ranjana Advani, Stephen M. Ansell, Christian Buske, Jorge J. Castillo, Ramón García-Sanz, Morie Gertz, Eva Kimby, Charalampia Kyriakou, Giampaolo Merlini, Monique C. Minnema, Pierre Morel, Enrica Morra, Mathias Rummel, Ashutosh Wechalekar, Christopher J. Patterson, Steven P. Treon, Meletios A. Dimopoulos
Journal: Blood
Blood (2016) 128 (10): 1321–1328.
https://doi.org/10.1182/blood-2016-04-711234
Published: 2016
Journal Articles

Prefmab: Final Analysis of Patient Preference for Subcutaneous Versus Intravenous Rituximab in Previously Untreated CD20+ Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Mathias Rummel, MD PhD, Tae Min Kim, MD PhD, Caterina Plenteda, MD, Enrico Capochiani, MD, Maria Mendoza, Rodney Smith, MD PhD, Stuart Osborne, MSc, Andrew Grigg, MBBS, MD FRACP, FRACPA
Journal: Blood
Blood (2015) 126 (23): 3972.
https://doi.org/10.1182/blood.V126.23.3972.3972
Published: 2015
Journal Articles

Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

Meletios A. Dimopoulos, Efstathios Kastritis, Roger G. Owen, Robert A. Kyle, Ola Landgren, Enrica Morra, Xavier Leleu, Ramón García-Sanz, Nikhil Munshi, Kenneth C. Anderson, Evangelos Terpos, Irene M. Ghobrial, Pierre Morel, David Maloney, Mathias Rummel, Véronique Leblond, Ranjana H. Advani, Morie A. Gertz, Charalampia Kyriakou, Sheeba K. Thomas, Bart Barlogie, Stephanie A. Gregory, Eva Kimby, Giampaolo Merlini, Steven P. Treon
Journal: Blood
Blood (2014) 124 (9): 1404–1411.
https://doi.org/10.1182/blood-2014-03-565135
Published: 2014
Journal Articles

Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG)

Peter Paschka, Juan Du, Richard F. Schlenk, Verena I. Gaidzik, Lars Bullinger, Andrea Corbacioglu, Daniela Späth, Sabine Kayser, Brigitte Schlegelberger, Jürgen Krauter, Arnold Ganser, Claus-Henning Köhne, Gerhard Held, Marie von Lilienfeld-Toal, Heinz Kirchen, Mathias Rummel, Katharina Götze, Heinz-August Horst, Mark Ringhoffer, Michael Lübbert, Mohammed Wattad, Helmut R. Salih, Andrea Kündgen, Hartmut Döhner, Konstanze Döhner
Journal: Blood
Blood (2013) 121 (1): 170–177.
https://doi.org/10.1182/blood-2012-05-431486
Published: 2013
Includes: Supplemental data
Journal Articles

Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies

Clinical Trials & Observations
Sabine Kayser, Manuela Zucknick, Konstanze Döhner, Jürgen Krauter, Claus-Henning Köhne, Heinz A. Horst, Gerhard Held, Marie von Lilienfeld-Toal, Sibylla Wilhelm, Mathias Rummel, Ulrich Germing, Katharina Götze, David Nachbaur, Brigitte Schlegelberger, Gudrun Göhring, Daniela Späth, Carina Morlok, Veronica Teleanu, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk, for the German-Austrian AML Study Group
Journal: Blood
Blood (2012) 119 (2): 551–558.
https://doi.org/10.1182/blood-2011-07-367508
Published: 2012
Includes: Supplemental data
Journal Articles

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML

Clinical Trials & Observations
Sabine Kayser, Konstanze Döhner, Jürgen Krauter, Claus-Henning Köhne, Heinz A. Horst, Gerhard Held, Marie von Lilienfeld-Toal, Sibylla Wilhelm, Andrea Kündgen, Katharina Götze, Mathias Rummel, David Nachbaur, Brigitte Schlegelberger, Gudrun Göhring, Daniela Späth, Carina Morlok, Manuela Zucknick, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk, for the German-Austrian AMLSG
Journal: Blood
Blood (2011) 117 (7): 2137–2145.
https://doi.org/10.1182/blood-2010-08-301713
Published: 2011
Includes: Supplemental data
Journal Articles

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct to High-Dose Cytarabine-Based Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of AMLSG 05-04 Trial.

Richard F. Schlenk, MD, Konstanze Döhner, MD, Jürgen Krauter, MD, Daniela Späth, Francesco de Valle, MD, Björn Heydrich, MD, Heinz A. Horst, MD, Ingo Schmidt-Wolf, MD, Mathias Rummel, MD, Katharina Götze, MD, Elisabeth Koller, MD, Andreas Petzer, MD, Hans G. Mergenthaler, MD, Hans Salwender, MD, Walter Fiedler, MD, Heinz Kirchen, MD, Detlef Haase, MD, Stefan Krämers, MD, Matthias Theobald, MD, Axel C. Matzdorff, MD, Arnold Ganser, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2007) 110 (11): 1837.
https://doi.org/10.1182/blood.V110.11.1837.1837
Published: 2007
Journal Articles

Bortezomib Is Not Active in Patients with Relapsed Hodgkin’s Lymphoma: Results of a Prematurely Closed Phase II Study.

Sven Trelle, Orhan Sezer, Ralph Naumann, Mathias Rummel, Ulrich Keller, Maike Nickelsen, Andreas Engert, Peter Borchmann
Journal: Blood
Blood (2006) 108 (11): 2477.
https://doi.org/10.1182/blood.V108.11.2477.2477
Published: 2006